New Study Identifies Four Glycaemic Phenotypes in Older Adults with Type 2 Diabetes
A recent analysis reveals distinct glucose patterns linked to metabolic differences in older adults with Type 2 diabetes.
Four unique glycaemic phenotypes were identified among older adults with Type 2 diabetes.
High glucose exposure with low variability correlates strongly with advanced cardiovascular-kidney-metabolic syndrome.
Further research is necessary to explore the implications of these findings on diabetes management.
A recent study utilizing continuous glucose monitoring (CGM) has uncovered four distinct glycaemic phenotypes in older adults diagnosed with Type 2 diabetes. Conducted on a sample of 2,491 individuals aged 60 and above, the research aimed to explore the metabolic characteristics associated with these phenotypes and their relationship to cardiovascular-kidney-metabolic (CKM) syndrome. The findings suggest that certain glucose patterns can provide insights into the health risks faced by this demographic.
The study involved participants who had been on stable glucose-lowering treatments for at least three months prior to the monitoring, which lasted for seven days. Researchers classified CKM syndrome based on criteria set by the American Heart Association, identifying that approximately 65% of the participants exhibited advanced stages of this syndrome. The analysis focused on two critical measurements: Time Above Range (TAR) and Mean Amplitude of Glycemic Excursion (MAGE), which were used to categorize the participants into four phenotypes based on their glucose levels.
Among the identified phenotypes, those exhibiting high TAR and low MAGE demonstrated the most significant association with advanced CKM syndrome, with a prevalence rate of 73.3%. This group also showed the highest fasting plasma glucose and triglyceride levels, indicating a pattern dominated by fasting hyperglycaemia. Interestingly, despite having the highest median HbA1c levels of 9.1%, the overall glycaemic control in this phenotype was not the poorest, highlighting the complexity of metabolic responses in this population.
The implications of these findings are considerable, as they suggest that traditional glycaemic indicators may not fully capture the metabolic diversity present in older adults with Type 2 diabetes. The researchers propose that CGM-derived phenotypes could offer a more nuanced understanding of metabolic health, potentially guiding more personalized treatment approaches. However, they emphasize the need for further prospective studies to validate these results and assess their predictive value regarding CKM progression and related health outcomes.
Looking ahead, the research team calls for additional investigations to explore the clinical significance of these glycaemic phenotypes. Understanding how these distinct patterns influence the progression of CKM syndrome could lead to improved management strategies for older adults living with Type 2 diabetes, ultimately enhancing their quality of life and health outcomes.




